Kannan Murugan

Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis

Pravin S. Shirude, Prashanti Madhavapeddi, Maruti Naik et al. · Journal of Medicinal Chemistry · 2013 · 101 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating <i>Mycobacterium tuberculosis</i>

Pravin S. Shirude, Prashanti Madhavapeddi, Julie A. Tucker et al. · ACS Chemical Biology · 2012 · 88 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate

Shahul Hameed P, Suresh Solapure, Vikas Patil et al. · Nature Communications · 2015 · 76 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure–activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose 2′-oxidase

Sudhir Landge, Amrita B. Mullick, Kavitha Nagalapur et al. · Bioorganic & Medicinal Chemistry · 2015 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Structure Guided Lead Generation for <i>M. tuberculosis</i> Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors

Maruti Naik, Anandkumar Raichurkar, Balachandra Bandodkar et al. · Journal of Medicinal Chemistry · 2014 · 45 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17